Startup Funding Tracker
Home›Companies›Healthcare›Pneuma Respiratory

Pneuma Respiratory, Inc.

Develops inhaled drug delivery devices for people with lung conditions.

ActiveHealthcare · Medical devices
Updated Nov 10, 2026·Latest SEC filing Jul 1, 2026·Suggest an edit

About Pneuma Respiratory

Pneuma Respiratory is a private company based in Boone, North Carolina. It has reported $38,082,307 raised in nine offerings on Form D since March 2018. Its chief executive is C. Hunter.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 18, 2026Jul 1, 2026$3,570,115target not set19$187KEquity, Options, Common Stock and Warrants to Purchase Common StockRule 506(b)Form D ↗
Feb 10, 2025Jun 23, 2025amended Dec 3, 2025$3,304,000fully sold14$236KDebt, Options, Convertible Notes and Warrants to Purchase Common StockRule 506(b)Form D/A ↗1 earlier filing
Nov 29, 2024May 13, 2025amended Dec 3, 2025$2,996,000fully sold26$115KDebt, Options, Convertible Notes and Warrants to Puchase Common StockRule 506(b)Form D/A ↗2 earlier filings
Jun 20, 2023Dec 23, 2024$7,340,000target not set68$107KEquity, OptionsRule 506(b)Form D ↗
Jun 18, 2020Feb 18, 2021$437,794of $3.0M target4$109KEquity, OptionsRule 506(b)Form D ↗
Aug 21, 2020Feb 18, 2021$429,585fully sold18$23,866OptionsRule 506(b)Form D ↗
Jul 15, 2019Jul 30, 2019amended Aug 10, 2021$6,898,219of $10.0M target36$191KEquityRule 506(b)Form D/A ↗3 earlier filings
Feb 25, 2019Mar 12, 2019amended Jul 30, 2019$4,999,906fully sold34$147KEquityRule 506(b)Form D/A ↗5 earlier filings
Mar 13, 2018Mar 23, 2018amended May 31, 2018$8,106,688of $15.0M target52$155KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, nine offerings$38,082,307

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pneuma Respiratory's Form D filed Jul 1, 2026.

J. Singleton
J. Singleton
Director
C. Hunter
C. Hunter
Founder & CEO, director
Jay Morgan
Douglas Stoner
JH
John Hand
Director
Farrukh Hameed

Earlier filings also listed May Shen (chief financial officer, last listed Dec 2024), Sally Yanchus (vice president of finance, last listed Aug 2021), Farnkh Hameed (director, last listed Aug 2021), J. Morgan (chairman of the board, last listed Feb 2021), Douglas Singleton (director, last listed Feb 2021), Wei Zheng (director, last listed Jul 2019), Walter Robb (chairman of the board, last listed Jul 2019) and Richard Gimigliano (executive officer, last listed Jul 2019).

Sources

  1. SECPneuma Respiratory, Inc. Form D, filed Jun 23, 2025
  2. SECPneuma Respiratory, Inc. Form D/A, filed May 14, 2025
  3. SECPneuma Respiratory, Inc. Form D, filed May 13, 2025
  4. SECPneuma Respiratory, Inc. Form D/A, filed Feb 17, 2021
  5. SECPneuma Respiratory, Inc. Form D/A, filed Feb 21, 2020
  6. SECPneuma Respiratory, Inc. Form D, filed Jul 30, 2019
  7. SECPneuma Respiratory, Inc. Form D/A, filed May 17, 2019
  8. SECPneuma Respiratory, Inc. Form D/A, filed May 6, 2019
  9. SECPneuma Respiratory, Inc. Form D/A, filed Apr 18, 2019
  10. SECPneuma Respiratory, Inc. Form D/A, filed Apr 5, 2019
  11. SECPneuma Respiratory, Inc. Form D, filed Mar 12, 2019
  12. SECPneuma Respiratory, Inc. Form D, filed Mar 23, 2018
  13. SECPneuma Respiratory, Inc. filing history
  14. CompanyPneuma Respiratory contact
  15. CompanyPneuma Respiratory leadership team
  16. PressJ. Knox Singleton joins Pneuma Respiratory